Active ingredient | Conc. (µg/cm2) | Lower limit | Upper limit | Commercial preparation | Conc. (µg/cm2) | Lower limit | Upper limit |
---|---|---|---|---|---|---|---|
Thiacloprid | Calypso | ||||||
LC10 | 0.108 | − 0.051 | 0.267 | LC10 | 0.013 | 0.010 | 0.017 |
LC50 | 0.510a | 0.774 | 1.794 | LC50 | 0.032b | 0.027 | 0.036 |
LC90 | 2.407 | − 8.917 | 13.730 | LC90 | 0.075 | 0.046 | 0.103 |
Esfenvalerate | Sumialfa | ||||||
LC10 | 0.017 | 0.011 | 0.023 | LC10 | 0.015 | − 0.0003 | 0.031 |
LC50 | 0.032a | 0.026 | 0.040 | LC50 | 0.084a | 0.034 | 0.134 |
LC90 | 0.063 | 0.035 | 0.090 | LC90 | 0.462 | − 0.234 | 1.159 |
Dimethenamid-p | Frontier | ||||||
LC10 | 3.503 | 2.936 | 4.071 | LC10 | 1.387 | 0.863 | 1.912 |
LC50 | 6.042a | 5.482 | 6.602 | LC50 | 2.524b | 1.954 | 3.095 |
LC90 | 10.42 | 7.973 | 12.867 | LC90 | 4.593 | 1.867 | 7.319 |
Prosulfocarb | Filon | ||||||
LC10 | 5.138 | 2.197 | 8.073 | LC10 | 2.373 | 0.592 | 4.154 |
LC50 | 12.464a | 7.257 | 17.671 | LC50 | 8.473a | 4.475 | 12.470 |
LC90 | 30.256 | − 3.313 | 63.826 | LC90 | 30.245 | − 8.622 | 69.112 |